Radiation Therapy for Advanced Gallbladder Cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a type of radiation therapy for people with advanced gallbladder cancer that cannot be removed by surgery. It is for those whose cancer has not spread to other parts of the body and has stayed stable or improved after initial chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of adenocarcinoma (a type of gallbladder cancer).
- The cancer is locally advanced, meaning it has spread nearby but not to distant organs.
- You have completed at least 3 months of gemcitabine-based chemotherapy and your cancer is stable or partially shrunk.
- You are at least 18 years old and in good enough health (ECOG 0-2) to receive chemotherapy.
- Your blood counts, liver, and kidney function must be within certain safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a combination of four drugs (gemcitabine, cisplatin, nab-paclitaxel, and durvalumab) for people with gallbladder cancer that has spread or cannot be removed by surgery. The goal is to see if this drug combination helps shrink or control the cancer.
This trial tests a new approach for gallbladder cancer that has grown into nearby areas but hasn't spread far. It combines a drug called AK112 (a type of immunotherapy that helps your immune system fight cancer) with standard chemotherapy and an anti-angiogenesis drug (GAP) before surgery, in the hope of shrinking the tumor enough to allow successful surgery.
This trial tests whether giving additional radiation therapy (called consolidative radiotherapy) to people with bile duct or gallbladder cancer that hasn't grown after initial chemotherapy can help control the disease for longer. It is for people whose cancer has spread to a limited number of places (oligometastatic) or is locally advanced and can't be removed surgically.
This trial tests a combination of chemotherapy, immunotherapy, and heat therapy (hyperthermia) with a special radiation technique for advanced bile duct or gallbladder cancer that hasn't been treated before. It aims to see if this combination can help shrink tumors and improve outcomes.
This Phase 2 trial tests a combination of cancer medicines (gemcitabine plus albumin-paclitaxel) along with immune therapy (sintilimab) and a blood-vessel–targeting drug (bevacizumab). It’s for people with gallbladder cancer that can’t be removed by surgery, to see if the treatment controls the cancer and improves outcomes.
This trial tests whether giving chemotherapy before surgery helps people with locally advanced gallbladder cancer that can still be removed. It may improve outcomes by shrinking the tumor beforehand.
Hear when a new Gall Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.